OGN
Organon & Co
13.70$
+0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.2% | +1.5% | -0.9% | -1.6% | +0.6% | -5.0% | +5.4% | +0.5% | -5.9% | -3.1% | +6.7% | – | |
| – | +11.6% | -2.6% | +0.5% | -1.3% | +5.6% | -3.4% | +7.1% | +3.5% | +0.4% | -9.5% | +5.0% | – | |
| – | +0.9% | +4.6% | -1.9% | -1.7% | -2.9% | -6.1% | +3.9% | -1.9% | -11.4% | +3.2% | +8.2% | – | |
| – | -2.2% | -16.4% | +3.6% | -4.3% | +17.1% | -26.2% | -1.0% | -11.6% | +8.3% | +2.2% | -3.2% | – | |
| – | -47.7% | +65.8% | +1.4% | -3.4% | -37.4% | +59.1% | +7.9% | -8.4% | +4.3% | -2.1% | +2.4% | – | |
| – | -10.7% | -10.0% | +1.8% | -3.6% | +12.6% | -14.0% | +6.2% | -8.9% | +5.0% | -1.3% | +1.4% | – | |
| – | +34.5% | +32.7% | -6.8% | +1.0% | -24.1% | +9.8% | +0.3% | +9.8% | -34.4% | +13.2% | +21.4% | – | |
| – | -3.7% | +1.6% | +0.0% | -3.8% | +4.8% | -6.1% | +6.5% | -3.0% | -5.5% | -8.3% | -2.7% | – | |
| – | +30.0% | +126.9% | -0.4% | -11.9% | -37.7% | -21.7% | +126.7% | +6.1% | -160.9% | – | -14.1% | – | |
| – | -2,109.1% | – | +14.3% | -480.0% | – | -30.0% | +500.0% | -1.2% | -31.3% | +17.5% | +11.9% | – | |
| – | +841.4% | -63.2% | -3.0% | +84.1% | -69.6% | -20.2% | +66.7% | +10.3% | -228.1% | – | -26.0% | – | |
| – | +6.5% | +47.4% | +0.0% | -6.9% | -15.2% | -4.7% | +38.2% | +2.4% | -85.9% | +530.8% | -9.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.